Erbitux Inquiry Could Yield Pre-Approval Speech Bill – Rep. Greenwood

The House Energy & Commerce Committee is still interested in pursuing legislation to increase FDA's authority to regulate pre-approval promotions as a follow-up to the Erbitux investigation

More from Archive

More from Pink Sheet